| For: | Liu X, Pan LX, Pei JX, Pu T, Wen HT, Zhao Y. Role of serological biomarkers in evaluating and predicting endoscopic activity in inflammatory bowel disease. World J Gastroenterol 2025; 31(18): 104206 [PMID: 40496365 DOI: 10.3748/wjg.v31.i18.104206] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i18/104206.htm |
| Number | Citing Articles |
| 1 |
Yunus H Polat, Başak Çakal, Salim Tece, Ilhami Yuksel. Red cell distribution width as a biomarker of disease activity in ulcerative colitis and Crohn’s disease. World Journal of Gastroenterology 2026; 32(38): 121569 doi: 10.3748/wjg.121569
|
| 2 |
Mohannad O. Khrieba, Furqan M. Abdulelah, Amal Mohammed Badawoud, Eman Hamza, Reham A. Al-Dhelaan, Tarek I. Ahmed, Ahmed G. Abdelhameed, Nora Elshorbagi, Doaa A. El-Hanafy, Nashwa Eltantawy, Muhammed M. Salahuddin, Noha M. Elkhodary, Kholoud H. Radwan, Khaled Abo Bakr Khalaf Ali, Abeer A. El-Sayed, Marwa Kamal. Adjunctive Pentoxifylline Enhances Clinical Remission and Reduces Inflammatory Biomarkers in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-Controlled Pilot Trial. Pharmaceuticals 2026; 19(4) doi: 10.3390/ph19040552
|
| 3 |
Ana Homšek Ilić, Marija Jovanović, Srđan Marković, Sandra Vezmar Kovačević, Tamara Knežević Ivanovski, Petar Svorcan, Radojka Savić, Katarina Vučićević. Connecting the Dots Between Pharmacokinetics, Inflammatory Biomarkers, and Mucosal Healing in Patients on Infliximab with Inflammatory Bowel Disease. Pharmaceutics 2026; 18(9) doi: 10.3390/pharmaceutics18091146
|
| 4 |
M. Daniyal Ghauri, Maria Victoria Fernandez, Giovanni Santacroce, Sumedha Chanda, Irene Zammarchi, Ivan Capobianco, Sanathana Konugolu Venkata Sekar, Subrata Ghosh, Katarzyna Komolibus, Stefan Andersson‐Engels, Marietta Iacucci, Rekha Gautam. Biomolecular Fingerprint of Crohn's Disease: A Comparative Raman Spectroscopic Study of Blood and Tissue Samples. Journal of Biophotonics 2026; 19(1) doi: 10.1002/jbio.70219
|
| 5 |
Jalpa Devi, Sami Samaan, Gaurav Syal, Parakkal Deepak. Biomarkers for Disease Activity in Inflammatory Bowel Disease. Gastroenterology Clinics of North America 2026; 55(1) doi: 10.1016/j.gtc.2025.08.003
|
| 6 |
Ping Lin, Wei Wang, Yun Zhou, Yong Yang, Ping Liu. Development and validation of a predictive nomogram for response to biologics and targeted therapy in Crohn’s disease: a retrospective cohort study. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1788290
|
| 7 |
Marsela Sina, Sara Hoxha, Xhensila Pemaj, Gentiana Qirjako, Enkeleint A. Mechili, Skerdi Prifti. Enteric Infections in Relapsing Ulcerative Colitis Patients in Albania: The Predictive Value of CRP/Albumin Ratio. Gastrointestinal Disorders 2026; 8(3) doi: 10.3390/gidisord8030035
|